title: Correlation between early neonatal diet and atopic symptoms up to 5-7 years of age in very low birth weight infants: follow-up of randomized, double-blind study.
abstract: The influence of early feeding on the risk of atopic diseases has been studied in full-term newborns, not in very low birth weight infants (VLBW). The study evaluated effect of early feeding of VLBW infants with either cow's milk-based formula (CMF) or extensively hydrolyzed milk formula (HF) on incidence of atopic diseases and markers of atopy at 5-7 years of age. This was a follow-up of the randomized, double-blind study evaluating the influence of different enteral feeding protocols on the early morbidity of VLBW infants. In the original study 80 children were randomly allocated into 2 groups receiving during first month of life HF (experimental group) or CMF (control group). At the age of 5-7 years, 62 children among 74 available (84%) with mean birthweight 1124g were evaluated according to standardized ISAAC (International Study of Asthma and Allergies in Childhood) protocol. Total IgE level, specific IgE, lymphocyte CD4+CCR4+/CD4+CXCR3+ ratio and skin prick tests (SPT) were done. Prevalence of obvious allergic diseases was not significantly different between the studied groups (HF: 12/33; CMF: 6/29; RR [relative risk] HF vs CMF: 1.76; 95%CI [confidence interval]: 0.76-4.09). Comparison of atopic status across groups revealed similar rate of positive markers of atopy: IgE (RR: 2.57 95%CI: 0.91-8,08), SPT (RR: 5.13; 95%CI: 0.93-31.6), lymphocyte CD4+CCR4+/CD4+CXCR3+ ratio (OR: 2.32; 95%CI: 0.78-7.53) in the both studied groups. Based on the carried out follow-up study we were unable to confirm the usefulness of hydrolyzed formula in prevention of allergy in an unselected cohort of very low birth weight infants.
authors.affiliation: Jagiellonian University, Department of Pediatrics, 30-663 Kraków, Ul. Wielicka 265, Poland. kwintap@mp.p
authors.forename: Przemko
authors.initials: P
authors.lastname: Kwinta
authors.forename: Piotr
authors.initials: P
authors.lastname: Sawiec
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Klimek
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Lis
authors.forename: Ewa
authors.initials: E
authors.lastname: Cichocka-Jarosz
authors.forename: Jacek Józef
authors.initials: JJ
authors.lastname: Pietrzyk
mesh_terms: D000818:Animals; D002417:Cattle; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D007073:Immunoglobulin E / Q000097:blood; D015994:Incidence; D041943:Infant Formula / Q000008:administration & dosage* / Q000737:chemistry; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D019102:Infant, Very Low Birth Weight; D008297:Male; D008892:Milk / Q000737:chemistry; D012882:Skin Tests; D016896:Treatment Outcome
chemical_list: D007073:Immunoglobulin E